Edition:
United States

Presbia PLC (LENS.OQ)

LENS.OQ on NASDAQ Stock Exchange Capital Market

1.64USD
4:00pm EDT
Change (% chg)

$-0.11 (-6.29%)
Prev Close
$1.75
Open
$1.65
Day's High
$1.72
Day's Low
$1.64
Volume
2,769
Avg. Vol
3,155
52-wk High
$7.00
52-wk Low
$1.64

Latest Key Developments (Source: Significant Developments)

Presbia Appoints Casey Lind As Chief Operating Officer
Tuesday, 13 Feb 2018 07:00pm EST 

Feb 13 (Reuters) - Presbia Plc ::PRESBIA ANNOUNCES NEW MANAGEMENT APPOINTMENTS.PRESBIA PLC SAYS CASEY LIND HAS BEEN APPOINTED AS CHIEF OPERATING OFFICER EFFECTIVE FEBRUARY 12, 2018.  Full Article

Presbia says terminates nearly half of its workforce
Thursday, 14 Dec 2017 05:13pm EST 

Dec 14 (Reuters) - Presbia Plc ::PRESBIA SAYS TERMINATED 15 EMPLOYEES OUT OF ITS 39 EMPLOYEES - SEC FILING.PRESBIA PLC - "COMPANY IS ALSO IN PROCESS OF IMPLEMENTING OTHER COST SAVING INITIATIVES".  Full Article

Presbia reports subscription price per whole share $3
Thursday, 26 Jan 2017 04:59pm EST 

Presbia Plc - : Presbia announces price and key dates related to rights offering . Subscription price per whole share is $3.00 .Under rights offering, Presbia plans to offer up to 4.5 million ordinary shares.  Full Article

Presbia reports certain interim data from its U.S. staged pivotal clinical trial
Thursday, 22 Dec 2016 05:02pm EST 

Presbia PLC : Presbia PLC says through November 30, 2016, 421 subjects have undergone insertion of Microlens during staged pivotal clinic trial . Presbia PLC says reports certain interim data from its U.S. staged pivotal clinical trial .Presbia PLC- currently, company is 24 months into its 3-year pivotal study and anticipates submitting data to FDA in September 2017.  Full Article

Presbia files for common stock offering of up to $13.5 mln
Monday, 5 Dec 2016 05:20pm EST 

Presbia Plc :Files for common stock offering of up to $13.5 million - SEC filing.  Full Article